adesso Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
adesso heeft een totaal eigen vermogen van €196.3M en een totale schuld van €195.7M, wat de schuld-eigenvermogensverhouding op 99.7% brengt. De totale activa en totale passiva bedragen respectievelijk €892.8M en €696.4M. De EBIT adesso is €62.4M waardoor de rentedekking 5.3 is. Het heeft contanten en kortetermijnbeleggingen van €57.7M.
Belangrijke informatie
99.69%
Verhouding schuld/eigen vermogen
€195.72m
Schuld
| Rente dekkingsratio | 5.3x |
| Contant | €57.73m |
| Aandelen | €196.34m |
| Totaal verplichtingen | €696.45m |
| Totaal activa | €892.78m |
Recente financiële gezondheidsupdates
Analyseartikel • Jan 22
adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Nov 02
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Oct 11
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Feb 11
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Recent updates
Narratiefupdate • May 09
ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential
Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Narratiefupdate • Apr 24
ADN1: Higher Discount Rate Will Create Long Term Opportunity
Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).Narratiefupdate • Apr 10
ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential
Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.Analyseartikel • Apr 07
Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality
When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...Analyseartikel • Feb 12
The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%
The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...Analyseartikel • Jan 22
adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Oct 19
Is There Now An Opportunity In adesso SE (ETR:ADN1)?
adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...Analyseartikel • Sep 12
A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb
adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...Analyseartikel • Sep 10
Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • May 25
Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business
adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...Analyseartikel • Feb 25
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75
The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
Nieuw narratief • Feb 07
Ongoing IT Investments Will Transform Operations By Mid-2025
Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.Analyseartikel • Dec 02
Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump
adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...Analyseartikel • Nov 22
adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...Analyseartikel • Nov 17
adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target
The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...Analyseartikel • Nov 02
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Aug 28
It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks
The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...Analyseartikel • May 21
adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year
The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...Analyseartikel • Apr 19
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70
The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...Analyseartikel • Apr 18
Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analyseartikel • Apr 02
Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality
The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...Analyseartikel • Mar 28
Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results
Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...Analyseartikel • Mar 23
Is adesso SE (ETR:ADN1) Trading At A 44% Discount?
Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...Analyseartikel • Mar 08
adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward
adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...Analyseartikel • Dec 14
A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)
Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...Analyseartikel • Oct 11
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Jul 22
At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...Analyseartikel • Jun 15
Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)
Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...Analyseartikel • May 09
adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Analyseartikel • Apr 22
What Does adesso SE's (ETR:ADN1) Share Price Indicate?
While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...Analyseartikel • Feb 11
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Jan 26
Returns On Capital At adesso (ETR:ADN1) Have Stalled
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Analyseartikel • Jan 10
Calculating The Fair Value Of adesso SE (ETR:ADN1)
How far off is adesso SE ( ETR:ADN1 ) from its intrinsic value? Using the most recent financial data, we'll take a look...Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( €442.5M ) ADN1 } overtreffen de korte termijn passiva ( €348.1M ).
Langlopende schulden: De kortetermijnactiva ADN1 ( €442.5M ) overtreffen de langetermijnschulden ( €348.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 70.3% ) ADN1 wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van ADN1 is de afgelopen 5 jaar gedaald van 138% naar 99.7%.
Schuldendekking: De schuld van ADN1 wordt goed gedekt door de operationele kasstroom ( 42.4% ).
Rentedekking: De rentebetalingen op de schuld van ADN1 worden goed gedekt door EBIT ( 5.3 x dekking).
Balans
Ontdek gezonde bedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/21 02:17 |
| Aandelenkoers aan het einde van de dag | 2026/05/21 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
adesso SE wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Daniel Großjohann | BankM AG |
| Wolfgang Specht | Berenberg |
| Finn Kemper | Hauck Aufhäuser Investment Banking |